韩国釜山综合医院 2 型糖尿病患者的处方现状。
Current status of prescription in type 2 diabetic patients from general hospitals in busan.
机构信息
Division of Endocrinology and Metabolism, Department of Internal Medicine, Woori Medical Clinic, Busan, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Busan St. Mary's Hospital, Busan, Korea.
出版信息
Diabetes Metab J. 2014 Jun;38(3):230-9. doi: 10.4093/dmj.2014.38.3.230. Epub 2014 Jun 17.
BACKGROUND
Data regarding the prescription status of individuals with diabetes are limited. This study was an analysis of participants from the relationship between cardiovascular disease and brachial-ankle pulse wave velocity in patients with type 2 diabetes (REBOUND) Study, which was a prospective multicenter cohort study recruited from eight general hospitals in Busan, Korea. We performed this study to investigate the current status of prescription in Korean type 2 diabetic patients.
METHODS
Type 2 diabetic patients aged 30 years or more were recruited and data were collected for demographics, medical history, medications, blood pressure, and laboratory tests.
RESULTS
Three thousands and fifty-eight type 2 diabetic patients were recruited. Mean age, duration of diabetes, and HbA1c were 59 years, 7.6 years, and 7.2%, respectively. Prevalence of hypertension was 66%. Overall, 7.3% of patients were treated with diet and exercise only, 68.2% with oral hypoglycemic agents (OHAs) only, 5.3% with insulin only, and 19.2% with both insulin and OHA. The percentage of patients using antihypertensive, antidyslipidemic, antiplatelet agents was similar as about 60%. The prevalence of statins and aspirin users was 52% and 32%, respectively.
CONCLUSION
In our study, two thirds of type 2 diabetic patients were treated with OHA only, and one fifth with insulin plus OHA, and 5% with insulin only. More than half of the patients were using each of antihypertensive, antidyslipidemic, or antiplatelet agents. About a half of the patients were treated with statins and one third were treated with aspirin.
背景
关于糖尿病患者处方状况的数据有限。本研究分析了来自韩国釜山八所综合医院的 2 型糖尿病患者心血管疾病与肱踝脉搏波速度关系（REBOUND）研究的参与者的数据。我们进行这项研究是为了调查韩国 2 型糖尿病患者的处方现状。
方法
招募年龄在 30 岁及以上的 2 型糖尿病患者，并收集人口统计学、病史、药物、血压和实验室检查等数据。
结果
共招募了 3058 名 2 型糖尿病患者。平均年龄、糖尿病病程和糖化血红蛋白（HbA1c）分别为 59 岁、7.6 年和 7.2%。高血压患病率为 66%。总体而言，7.3%的患者仅接受饮食和运动治疗，68.2%的患者仅接受口服降糖药（OHA）治疗，5.3%的患者仅接受胰岛素治疗，19.2%的患者同时接受胰岛素和 OHA 治疗。使用抗高血压药、调脂药和抗血小板药物的患者比例相似，约为 60%。他汀类药物和阿司匹林的使用率分别为 52%和 32%。
结论
在我们的研究中，三分之二的 2 型糖尿病患者仅接受 OHA 治疗，五分之一的患者同时接受胰岛素和 OHA 治疗，5%的患者仅接受胰岛素治疗。超过一半的患者使用每种降压药、调脂药或抗血小板药物。约一半的患者接受他汀类药物治疗，三分之一的患者接受阿司匹林治疗。
Zotero 插件